Clipping of news on Brazilian Culture, Law and Citizenship
12/2/2016
This article was translated by an automatic translation system, and was therefore not reviewed by people.
Transparent image
Ordinance of the Ministry of Health published today (2) in the Federal Official Gazette makes public the decision to incorporate into the Unified Health System (SUS) ombitasvir, veruprevir, ritonavir and dasabuvir drugs in the treatment of hepatitis C.
According to the text, the four incorporated drugs will be used in cases of chronic hepatitis caused by genotype 1 in individuals with advanced fibrosis and cirrhosis. The ordinance comes into effect today.
The disease
Hepatitis C is caused by the virus C (HCV), present in the blood. Among the most common causes of transmission are blood transfusion and sharing of material for use of drugs (syringes, needles, pipes, among others), personal hygiene (razor and epilator blades, toothbrushes, Other objects that pierce or cut) or for the making of tattooing and piercing.
Edition: Maria Claudia
Contact the Ombudsman
Source: Agência Brasil
Our news is removed in full from our partners' websites. For this reason, we can not change the content of these even in cases of typos.
This article was translated by an automatic translation system, and was therefore not reviewed by people.